EpiBesançon 2022 10&11 May
6th edition of EpiCongress
EpiBesançon 2022 is the 6th edition of international epigenetics congress. This meeting is co-organized by the Niches and Epigenetics of Tumors Network of Canceropole Grand Ouest and the epignetics group of INSERM UMR1098.
This congress is an opportunity for international researchers, PhD students, MD and private industrials to discuss about the development of epigenetic drugs through a better understanding of molecular mechanisms of epigenetics mainly in the ﬁeld of cancer. Thus, communications will be performed with the goal to inform scientiﬁc community about recent and innovative researches in epigenetics in fundamental ﬁeld and also in medicine/clinical applications.
Thus, we expect that this meeting would open the way to new epigenetic projects and promote new collaborations for your future research. After the virtual meeting that have been held in 2021 we are very happy to warmly welcome you in Besançon in May 2022.
Registration is open here ! Click here to register
Then go to Abstract Submission Guidlines if you want to submit a communication! (deadline 15st April 2022)
Anaïs Bardet, Interplay between transcription factors and DNA methylation in cancer, Strasbourg, France
Rachel Deplus, RNA modifications in cancer, Bruxelles, France
Jérôme Eeckhoute, Control of cellular identity in liver pathophysiology, Lille, France
Francesco Fazi, Non-coding RNA and N6-Methyladenosine (m6A) -dependent networks in cancer cell behavior, Roma Italy
Ciro Isidoro, Non-coding RNA epigenetic regulation of autophagy in cancer, Novara, Italy
Carmen Jeronimo, Non-coding RNAs in liquid biopsy as prostate cancer biomarkers, Porto, Portugal
Olivier Joffre, Epigenetic control of T helper cell programming, Toulouse, France
Hisham Mohammed, Transcriptional and epigenetic cell states and it’s impact on disease progression in breast cancer, Portland, USA
Marek Mraz, Impact of microenvionmental interactions on the biology of B cells malignancies, Brno, Czech Republic
Peter Mulligan, Regulation of cancer hallmarks by epigenetic reader proteins, Lyon, France
Duncan Odom, How unrepaired DNA lesions shape genome evolution, Heidelberg, Germany
Gilles Salbert, Epigenetic reprogramming of cancer cells, Rennes, France
Petr Svoboda, Small RNA-mediated innate and acquired genome immunity in rodents, Prague, Czech Republic
Céline Vallot, Dynamics of repressive epigenomes in cancer in response to treatment, Paris, France
Elina Zueva, Transposon-host interaction in immune cells, Paris, France